149 related articles for article (PubMed ID: 16226111)
1. Expression of the estrogen receptor beta in 37 surgically treated pulmonary sclerosing hemangiomas in comparison with non-small cell lung carcinomas.
Wu CT; Chang YL; Lee YC
Hum Pathol; 2005 Oct; 36(10):1108-12. PubMed ID: 16226111
[TBL] [Abstract][Full Text] [Related]
2. The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers.
Wu CT; Chang YL; Shih JY; Lee YC
J Thorac Cardiovasc Surg; 2005 Oct; 130(4):979-86. PubMed ID: 16214508
[TBL] [Abstract][Full Text] [Related]
3. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen.
Stabile LP; Davis AL; Gubish CT; Hopkins TM; Luketich JD; Christie N; Finkelstein S; Siegfried JM
Cancer Res; 2002 Apr; 62(7):2141-50. PubMed ID: 11929836
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor beta--which one and where should we draw the line?
Shaaban AM; Speirs V
Hum Pathol; 2006 Apr; 37(4):498; author reply 499-500. PubMed ID: 16564928
[No Abstract] [Full Text] [Related]
5. Highly concordant coexpression of aromatase and estrogen receptor beta in non-small cell lung cancer.
Abe K; Miki Y; Ono K; Mori M; Kakinuma H; Kou Y; Kudo N; Koguchi M; Niikawa H; Suzuki S; Evans DB; Sugawara S; Suzuki T; Sasano H
Hum Pathol; 2010 Feb; 41(2):190-8. PubMed ID: 19800101
[TBL] [Abstract][Full Text] [Related]
6. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival.
Skov BG; Fischer BM; Pappot H
Lung Cancer; 2008 Jan; 59(1):88-94. PubMed ID: 17905466
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma.
Niikawa H; Suzuki T; Miki Y; Suzuki S; Nagasaki S; Akahira J; Honma S; Evans DB; Hayashi S; Kondo T; Sasano H
Clin Cancer Res; 2008 Jul; 14(14):4417-26. PubMed ID: 18579664
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous expression of c-erbB-1, c-erbB-2, c-erbB-3 and c-erbB-4 receptors in non-small-cell lung carcinomas: correlation with clinical outcome.
Koutsopoulos AV; Mavroudis D; Dambaki KI; Souglakos J; Tzortzaki EG; Drositis J; Delides GS; Georgoulias V; Stathopoulos EN
Lung Cancer; 2007 Aug; 57(2):193-200. PubMed ID: 17442448
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological analysis of pulmonary sclerosing hemangioma.
Iyoda A; Hiroshima K; Shiba M; Haga Y; Moriya Y; Sekine Y; Shibuya K; Iizasa T; Fujisawa T
Ann Thorac Surg; 2004 Dec; 78(6):1928-31. PubMed ID: 15561002
[TBL] [Abstract][Full Text] [Related]
11. Different estrogen receptor beta expression in distinct histologic subtypes of lung adenocarcinoma.
Alì G; Donati V; Loggini B; Servadio A; Dell'Omodarme M; Prati MC; Camacci T; Lucchi M; Melfi F; Mussi A; Fontanini G
Hum Pathol; 2008 Oct; 39(10):1465-73. PubMed ID: 18620727
[TBL] [Abstract][Full Text] [Related]
12. Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers.
Omoto Y; Kobayashi Y; Nishida K; Tsuchiya E; Eguchi H; Nakagawa K; Ishikawa Y; Yamori T; Iwase H; Fujii Y; Warner M; Gustafsson JA; Hayashi SI
Biochem Biophys Res Commun; 2001 Jul; 285(2):340-7. PubMed ID: 11444848
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
14. Oestrogen receptor β in NSCLC - prevalence, proliferative influence, prognostic impact and smoking.
Karlsson C; Helenius G; Fernandes O; Karlsson MG
APMIS; 2012 Jun; 120(6):451-8. PubMed ID: 22583357
[TBL] [Abstract][Full Text] [Related]
15. WWOX expression in different histologic types and subtypes of non-small cell lung cancer.
Donati V; Fontanini G; Dell'Omodarme M; Prati MC; Nuti S; Lucchi M; Mussi A; Fabbri M; Basolo F; Croce CM; Aqeilan RI
Clin Cancer Res; 2007 Feb; 13(3):884-91. PubMed ID: 17289881
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
[TBL] [Abstract][Full Text] [Related]
17. Defective expression of transforming growth factor beta type II receptor (TGFBR2) in the large cell variant of non-small cell lung carcinoma.
Xu JB; Bao Y; Liu X; Liu Y; Huang S; Wang JC
Lung Cancer; 2007 Oct; 58(1):36-43. PubMed ID: 17566598
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and progesterone receptors in non small cell lung cancer patients.
Radzikowska E; Langfort R; Giedronowicz D
Ann Thorac Cardiovasc Surg; 2002 Apr; 8(2):69-73. PubMed ID: 12027790
[TBL] [Abstract][Full Text] [Related]
19. Combined overexpression of EGFR and estrogen receptor alpha correlates with a poor outcome in lung cancer.
Kawai H; Ishii A; Washiya K; Konno T; Kon H; Yamaya C; Ono I; Ogawa J
Anticancer Res; 2005; 25(6C):4693-8. PubMed ID: 16334162
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of estrogen receptors--ERalpha and ERbeta, in patients with lung cancer].
Uchikov A; Dimitrov I; Hadjiev B; Prisadov G; Uchikova E; Ganchevska P; Uzunova V
Khirurgiia (Sofiia); 2010; (1):32-5. PubMed ID: 21972702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]